Delivery Order SPE2DR25D1103-SPE2DR26FE844
- Not listed
- The Defense Logistics Agency awarded a $5,657.00 delivery order to AmerisourceBergen Drug Corp for 30-count bottles of ADDYI 100 mg tablets, with a completion date of December 1, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.28 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency has awarded a delivery order valued at $4,889.15 to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of June 2, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.74 to AmerisourceBergen Drug Corp for ADDYI (flibansergin) 100 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing work at its corporate office location. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $11,561.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets in quantities of 30 units. The contract was competitively awarded without set-aside designation and is scheduled for completion by December 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,037.90 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units). The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, employs firm fixed-price pricing and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets in quantities of 30 units, valued at $5,216.10 under a firm fixed price contract type. The award, issued on December 18, 2025, is a non-set-aside competitive action with an ultimate completion date of December 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location in the...
- The Defense Logistics Agency awarded a $17,263.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-unit supplies of ADDYI 100 mg tablets, with an ultimate completion date of January 7, 2026. This non-set-aside award was issued on January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves critical...
- The Defense Logistics Agency awarded a delivery order valued at $70,277.54 to AmerisourceBergen Drug Corp for 4,570,457,618 tablets of ADDYI 100 mg on January 9, 2026, with completion expected by January 12, 2026. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $35,858.57 to AmerisourceBergen Drug Corp for supply of ADDYI 100 mg tablets in quantities of 30-count units. The contract is a firm fixed price delivery order with an ultimate completion date of September 26, 2025, and was awarded on September 25, 2025, with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE844Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,940.51 to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) on January 16, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price, non-set-aside contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle through December 2026. The contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal military and veteran healthcare systems. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a critical vendor within the federal medical supply chain, fulfilling diverse pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capacity to deliver both brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities through open competition, positioning it as a key supplier for military treatment facilities and federal medical institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 1/15/26 |